News Medical on MSN1d
CityUHK researchers develop an innovative bio-detection platform for cancer early screening and disease monitoringCancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, ...
Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...
Professor Michael Yang (eighth from the left) and his research team.Cancer continues to be a leading cause of mortality ...
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...
Circulating tumor DNA (ctDNA ... We develop mathematical models of ctDNA kinetics arising from tumor cell population responses to targeted therapy, chemotherapy, and radiotherapy and examine how these ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Preoperative ...
Tethis S.p.A., a pioneer in standardized liquid biopsy platform development, and Sheba Medical Center, Israel's largest medical center consistently ranked as a Top 10 World's Best Hospital by Newsweek ...
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback